{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:23:34Z","timestamp":1792693414029,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012615","name":"The University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017236","name":"Huffington Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.prdoa.2023.100187","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T02:27:34Z","timestamp":1674786454000},"page":"100187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8847-2501","authenticated-orcid":false,"given":"Christopher","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessika","family":"Suescun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3707-9918","authenticated-orcid":false,"given":"Kelly","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivika","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-0044","authenticated-orcid":false,"given":"Timothy M.","family":"Ellmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-2587","authenticated-orcid":false,"given":"Mya C.","family":"Schiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"s1","key":"10.1016\/j.prdoa.2023.100187_b0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.prdoa.2023.100187_b0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/WNL.35.4.522","article-title":"The heterogeneity of Parkinson's disease: clinical and prognostic implications","volume":"35","author":"Zetusky","year":"1985","journal-title":"Neurology"},{"issue":"15\u201316","key":"10.1016\/j.prdoa.2023.100187_b0015","first-page":"384","article-title":"Clinical subtypes of Parkinson disease","volume":"136","author":"Poewe","year":"1986","journal-title":"Wien. Med. Wochenschr."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100187_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1353-8020(99)00051-6","article-title":"Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis","volume":"6","author":"Schiess","year":"2000","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.prdoa.2023.100187_b0025","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.prdoa.2023.100187_b0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2023.100187_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.637896","article-title":"Consistency and stability of motor subtype classifications in patients with de novo Parkinson's disease","volume":"15","author":"Ren","year":"2021","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.prdoa.2023.100187_b0040","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","article-title":"Disease progression in Parkinson subtypes: the PPMI dataset","volume":"39","author":"Aleksovski","year":"2018","journal-title":"Neurol. Sci."},{"issue":"8","key":"10.1016\/j.prdoa.2023.100187_b0045","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.10455","article-title":"Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study","volume":"18","author":"Burn","year":"2003","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.prdoa.2023.100187_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mds.23468","article-title":"Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography","volume":"26","author":"Eggers","year":"2011","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100187_b0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mdc3.13107","article-title":"Neuroimaging Detectable differences between Parkinson's disease motor subtypes: a systematic review","volume":"8","author":"Boonstra","year":"2021","journal-title":"Mov. Disord. Clin. Practice"},{"key":"10.1016\/j.prdoa.2023.100187_b0060","doi-asserted-by":"crossref","first-page":"44872","DOI":"10.1038\/srep44872","article-title":"Phenotype of postural instability\/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters","volume":"7","author":"Zuo","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100187_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jat\/26.1.17","article-title":"Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine","volume":"26","author":"Yamada","year":"2002","journal-title":"J. Anal. Toxicol."},{"issue":"4958","key":"10.1016\/j.prdoa.2023.100187_b0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/204587b0","article-title":"Distribution of homovanillic acid in the human brain","volume":"204","author":"Bernheimer","year":"1964","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prdoa.2023.100187_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174644","article-title":"Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype","volume":"12","author":"Huertas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prdoa.2023.100187_b0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jns.2016.10.035","article-title":"Resting-state functional connectivity of subthalamic nucleus in different Parkinson's disease phenotypes","volume":"371","author":"Wang","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.prdoa.2023.100187_b0085","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.22473","article-title":"Serotonin and Parkinson's disease: On movement, mood, and madness","volume":"24","author":"Fox","year":"2009","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.prdoa.2023.100187_b0090","article-title":"Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism","volume":"20","author":"Chase","year":"1970","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.prdoa.2023.100187_b0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/jnnp.40.12.1136","article-title":"CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders","volume":"40","author":"Davidson","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2-5","key":"10.1016\/j.prdoa.2023.100187_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000103680","article-title":"On the occurrence of homovanillic acid and 5-hydroxyindol-3-ylacetic acid in the ventricular C.S.F. of patients suffering from parkinsonism","volume":"29","author":"Guldberg","year":"1967","journal-title":"Confin. Neurol."},{"key":"10.1016\/j.prdoa.2023.100187_b0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","article-title":"Serotonin in Parkinson's disease","volume":"277","author":"Politis","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100187_b0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pneurobio.2011.08.004","article-title":"The serotonergic system in Parkinson's disease","volume":"95","author":"Huot","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.prdoa.2023.100187_b0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","article-title":"Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story","volume":"102","author":"Vermeiren","year":"2017","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100187_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.prdoa.2023.100187_b0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","article-title":"Altered serotonin metabolism in depressed patients with parkinson's disease","volume":"34","author":"Mayeux","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.prdoa.2023.100187_b0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(93)90111-W","article-title":"Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms","volume":"150","author":"Tohgi","year":"1993","journal-title":"Neurosci. Lett."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112523000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112523000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:46:40Z","timestamp":1762912000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112523000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":26,"alternative-id":["S2590112523000051"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2023.100187","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2023.100187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100187"}}